MARIAH ADEN: Open Payments
NPI 1073161485 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 31 payments from 10 companies in 2025. Trend: 2023 $361 · 2024 $1,672 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $205 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 4 | $62 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
| Alkermes, Inc. | 3 | $54 |
| Axsome Therapeutics, Inc. | 4 | $53 |
| ABBVIE INC. | 3 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Lundbeck LLC | 1 | $17 |
Products named: INGREZZA, CAPLYTA, REXULTI, ARISTADA, Auvelity, VRAYLAR, COBENFY, INVEGA SUSTENNA.
Industry payments across SC — which companies pay providers there.
